Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Younger postmenopausal women may not get enough calcium (opens in a new tab)

news-medical.net · 2026-10-06

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 3 supported
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Three of five claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.

  • 3 supported
  • 2 not covered
Open claim evidence
3

The source study

Dietary Calcium Intake in Patients Evaluated for Bone Fragility, with a Focus on Women Receiving Adjuvant Endocrine Therapy for Breast Cancer: A Single-Center Cross-Sectional Study

Nutrients · 2026
Open source record (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not coveredThe study included 122 females and 10 males evaluated at a single center in Italy between January 2020 and December 2021, using a food frequency questionnaire to assess seven-day dietary calcium intake along with bone and fracture-related measures.View evidenceHide evidence

As stated132 participants total; 959 mg/day average calcium intake overall

Why this verdict

The abstract-level profile supports several components: 132 first-time clinic referrals, single-center setting in Ancona, Italy, use of a 7-day food frequency questionnaire, collection of biochemical/densitometric parameters, osteoporosis etiology and fragility fracture history, and overall mean intake of 959 ± 396 mg/day. However, the specific sex breakdown of 122 females and 10 males and the January 2020–December 2021 recruitment window are not available in the supplied abstract-level profile, so the full presented claim is not verifiable at this depth.

1

Study evidence

Overall mean dietary calcium intake among the 132 clinic-referred patients was 959 ± 396 mg/day.959 ± 396 mg/day

“A Single-Center Cross-Sectional Study”
2

Study evidence

Cohort composition: predominantly postmenopausal women with 43.2% classified as having severe osteoporosis and 40.9% classified at risk of secondary osteoporosis.43.2% severe osteoporosis; 40.9% at risk of secondary osteoporosis

“...biochemical and densitometric parameters, osteoporosis etiology, and previous fragility fractures were also reported.”
Claim 2 of 5Not coveredThe authors are described as recommending individualized nutritional assessment and counseling to help patients meet calcium requirements, while noting the study's limitations and that the findings need confirmation in larger multicenter prospective studies.View evidenceHide evidence

Why this verdict

The abstract-level profile supports the general recommendation that patients with bone fragility should be encouraged to increase dietary calcium intake, with special attention to women on AET for breast cancer. But the more specific wording about individualized nutritional assessment and counseling, authors noting all listed limitations, and the need for confirmation in larger multicenter prospective studies is not fully present in the supplied abstract-level profile. Those details may be in the full text, but they are not verifiable at abstract depth.

1

Study evidence

Overall mean dietary calcium intake among the 132 clinic-referred patients was 959 ± 396 mg/day.959 ± 396 mg/day

“A Single-Center Cross-Sectional Study”
2

Study evidence

Women receiving adjuvant endocrine therapy for breast cancer had a mean dietary calcium intake of 854 ± 345 mg/day, reported as lower than the recommended threshold.854 ± 345 mg/day

“...with a particular focus on patients at risk of secondary osteoporosis due to adjuvant endocrine therapy (AET) for breast cancer (BC).”
Claim 3 of 5SupportedA recent study published in Nutrients suggests that younger postmenopausal women evaluated for bone fragility and women at high risk of osteoporosis and fragility fractures may be consuming less calcium than recommended in Italy.View evidenceHide evidence

Why this verdict

The abstract-level profile supports a hedged, associational lead claim that dietary calcium intake was low in relevant subgroups of this clinic-referred bone-fragility population. It reports lower mean intake in younger patients with postmenopausal osteoporosis (848 ± 471 mg/day, p = 0.03) and below-threshold mean intake in women receiving adjuvant endocrine therapy for breast cancer. The exact Italian recommended threshold is not specified in the abstract profile, but the broad framed point that intake was below or lower than recommended in these risk groups is consistent with the paper profile.

1

Study evidence

Overall mean dietary calcium intake among the 132 clinic-referred patients was 959 ± 396 mg/day.959 ± 396 mg/day

“A Single-Center Cross-Sectional Study”
2

Study evidence

Women receiving adjuvant endocrine therapy for breast cancer had a mean dietary calcium intake of 854 ± 345 mg/day, reported as lower than the recommended threshold.854 ± 345 mg/day

“...with a particular focus on patients at risk of secondary osteoporosis due to adjuvant endocrine therapy (AET) for breast cancer (BC).”
Claim 4 of 5SupportedIn the study, the average calcium consumption also remained below the recommended level among women receiving adjuvant endocrine therapy for breast cancer.View evidenceHide evidence

As statedaverage intake of 854 mg/day in women receiving adjuvant endocrine therapy

Why this verdict

The profile directly reports that women receiving adjuvant endocrine therapy for breast cancer had mean dietary calcium intake of 854 ± 345 mg/day and that this was described as below the recommended threshold. The abstract profile notes that the numerical threshold and statistical test versus threshold are not provided, but the story’s stated mean and direction match the profile.

1

Study evidence

Women receiving adjuvant endocrine therapy for breast cancer had a mean dietary calcium intake of 854 ± 345 mg/day, reported as lower than the recommended threshold.854 ± 345 mg/day

“...with a particular focus on patients at risk of secondary osteoporosis due to adjuvant endocrine therapy (AET) for breast cancer (BC).”
2

Study evidence

Overall mean dietary calcium intake among the 132 clinic-referred patients was 959 ± 396 mg/day.959 ± 396 mg/day

“A Single-Center Cross-Sectional Study”
Claim 5 of 5SupportedThe article says differences by normal bone mineral density, fracture status, and secondary osteoporosis did not reach statistical significance and should be treated as trends rather than established group differences.View evidenceHide evidence

Why this verdict

The paper profile states that patients with normal BMD, those without fragility fractures, and those evaluated for secondary osteoporosis had lower mean intakes as trends that did not reach statistical significance. The story’s framing that these should be treated as trends rather than established group differences is aligned with the profile and appropriately avoids overstating non-significant subgroup comparisons.

1

Study evidence

Overall mean dietary calcium intake among the 132 clinic-referred patients was 959 ± 396 mg/day.959 ± 396 mg/day

“A Single-Center Cross-Sectional Study”
2

Study evidence

Cohort composition: predominantly postmenopausal women with 43.2% classified as having severe osteoporosis and 40.9% classified at risk of secondary osteoporosis.43.2% severe osteoporosis; 40.9% at risk of secondary osteoporosis

“...biochemical and densitometric parameters, osteoporosis etiology, and previous fragility fractures were also reported.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Dietary calcium intake was estimated by self-reported 7-day food frequency questionnaire, which may introduce recall or reporting bias.

    The story notes use of a food frequency questionnaire but, based on the provided caveats, does not explicitly acknowledge self-report recall/reporting bias as a limitation. This is a relevant interpretation caveat for dietary intake estimates.

    From Cross-sectional subgroup analysis (clinic-referred cohort)

  • The abstract profile does not specify the numerical recommended calcium threshold used for comparison, nor statistical testing of the AET subgroup value against that threshold.

    The story presents below-recommended intake and an Italian recommendation framing without noting that the supplied abstract-level evidence does not specify the threshold or threshold-test details. This matters for interpreting the magnitude and certainty of the below-threshold claim at abstract depth.

    From Cross-sectional subgroup analysis (clinic-referred cohort)

8 things the story did carry across
  • The paper is a single-center cross-sectional observational study of 132 first-time referrals to an osteoporosis/bone metabolism outpatient clinic in Ancona, Italy, assessing dietary calcium intake with a 7-day FFQ.
  • Overall mean dietary calcium intake in the cohort was 959 ± 396 mg/day.
  • Younger patients with postmenopausal osteoporosis had lower mean dietary calcium intake, reported as 848 ± 471 mg/day with p = 0.03.
  • Women receiving adjuvant endocrine therapy for breast cancer were a highlighted high-risk subgroup and had mean dietary calcium intake of 854 ± 345 mg/day, below the study’s referenced recommended threshold.
  • Patients with normal BMD, patients without prior fragility fractures, and those evaluated for secondary osteoporosis showed lower mean intake patterns that did not reach statistical significance.
  • The authors conclude that patients with bone fragility should be encouraged to increase dietary calcium intake, with special attention to women on AET for breast cancer and possible use of selected dairy or alternative calcium sources.
  • Major design limitations include cross-sectional measurement, single-center clinic-based sampling, and limited generalizability/causal inference.
  • Subgroup analyses are limited by small or incompletely described subgroup sizes and limited statistical detail at abstract level, including lack of full adjustment/confounding information.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoQuantify dietary calcium intake in patients referred for first-time evaluation of bone fragility at a single outpatient osteoporosis clinic, and describe intake levels relative to patient subgroups.Single-center cross-sectional studyExpand

In plain English

Single-center cross-sectional study of 132 first-time referrals to an osteoporosis outpatient clinic assessing dietary calcium intake using a 7-day food frequency questionnaire, reporting overall mean intake and subgroup comparisons (age/BMD/fracture history/secondary osteoporosis, including women on adjuvant endocrine therapy for breast cancer).

Key findings

  • Overall mean dietary calcium intake among the 132 clinic-referred patients was 959 ± 396 mg/day.959 ± 396 mg/day
  • Younger patients with postmenopausal osteoporosis had lower mean dietary calcium intake compared with others in the sample.848 ± 471 mg/day
“A Single-Center Cross-Sectional Study”
What this piece can’t prove
  • Single-center, clinic-based sample of 132 first-time referrals (limits to generalizability to broader populations).
  • Cross-sectional design (assessments at a single time point; limits causal inference).

1 further detail could not be confirmed from the summary.

2human in vivoCharacterize calcium intake specifically in women receiving adjuvant endocrine therapy (AET) for breast cancer as a high-risk subgroup for secondary osteoporosis.Cross-sectional subgroup analysis (clinic-referred cohort)Expand

In plain English

In this single-center cross-sectional clinic-referred cohort (n = 132), women receiving adjuvant endocrine therapy (AET) for breast cancer — comprising a large proportion of those evaluated for secondary osteoporosis — had a mean reported dietary calcium intake below the study's referenced recommended threshold (854 ± 345 mg/day). The study assessed intake with a 7-day food frequency questionnaire and reported descriptive comparisons; subgroup-specific statistical significance versus the threshold is not reported in the abstract.

Key findings

  • Women receiving adjuvant endocrine therapy for breast cancer had a mean dietary calcium intake of 854 ± 345 mg/day, reported as lower than the recommended threshold.854 ± 345 mg/day
“...with a particular focus on patients at risk of secondary osteoporosis due to adjuvant endocrine therapy (AET) for breast cancer (BC).”
What this piece can’t prove
  • Single-center, cross-sectional observational design (limits causal inference and generalizability).
  • Dietary intake assessed by a 7-day food frequency questionnaire (self-report subject to recall and reporting bias).
  • Abstract does not report the numerical recommended threshold used for comparison nor the statistical test results for the AET subgroup vs threshold.

1 further detail could not be confirmed from the summary.

3human in vivoDescribe the clinical/biological context of the clinic-referred population (bone density category, osteoporosis etiology, biochemical/densitometric parameters, prior fragility fractures) as correlates/context for calcium intake comparisons.Cross-sectional clinic-based observationalExpand

In plain English

In a single-center cross-sectional clinic cohort of 132 patients referred for bone fragility assessment, the study recorded biochemical and densitometric parameters, classified osteoporosis etiology, and captured prior fragility fractures to contextualize comparisons of dietary calcium intake across clinical subgroups. The cohort was predominantly postmenopausal women; 43.2% had severe osteoporosis and 40.9% were classified at risk of secondary osteoporosis, of whom 64.8% were women receiving adjuvant endocrine therapy (AET) for breast cancer. Analyses reported subgroup mean calcium intakes (e.g., lower intake in younger patients with postmenopausal osteoporosis: 848 ± 471 mg/day, p = 0.03) and noted other subgroup patterns that did not reach statistical significance (normal BMD, no fragility fractures, secondary-osteoporosis evaluations). The abstract states biochemical and densitometric measures and fracture history were recorded but does not provide their detailed values in the abstract.

Key findings

  • Cohort composition: predominantly postmenopausal women with 43.2% classified as having severe osteoporosis and 40.9% classified at risk of secondary osteoporosis.43.2% severe osteoporosis; 40.9% at risk of secondary osteoporosis
  • Among patients evaluated for secondary osteoporosis, 64.8% were women receiving adjuvant endocrine therapy for breast cancer.64.8%
“...biochemical and densitometric parameters, osteoporosis etiology, and previous fragility fractures were also reported.”
What this piece can’t prove
  • Cross-sectional single-center design limits temporal/causal inference.
  • Sample size (n = 132) may limit power for subgroup comparisons; several subgroup differences reported did not reach statistical significance according to the abstract.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Dietary Calcium Intake in Patients Evaluated for Bone Fragility, with a Focus on Women Receiving Adjuvant Endocrine Therapy for Breast Cancer: A Single-Center Cross-Sectional Study

Nutrients · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, Europe PMC, PubMed · 40 candidate papers

Selected

Dietary Calcium Intake in Patients Evaluated for Bone Fragility, with a Focus on Women Receiving Adjuvant Endocrine Therapy for Breast Cancer: A Single-Center Cross-Sectional Study

Nutrients · 2026 · Crossref

Source (opens in a new tab)
Candidate

Review of: "Abdominal Subcutaneous Emphysema: a Rare Post-operative Complication in Aesthetic Breast Augmentation"

2026 · Crossref

Source (opens in a new tab)
Candidate

Author response for "Influence of climate and soil nutrients on the evolutionary abandonment of the arbuscular mycorrhizal symbiosis"

2026 · Crossref

Source (opens in a new tab)
Candidate

Author response for "Duckweed as a Sustainable Source: Extraction and Applications of Bioactive Nutrients for Industrial Applications"

2026 · Crossref

Source (opens in a new tab)

And 34 more candidates considered.